fda approves semaglutide for cardiovascular risk reduction Wegovy FDA Approves OZEMPIC (Semaglutide) to

Graphical abstract Similar content being viewed by others Introduction Kidney transplantation is recognized as the best treatment option for most patients with end-stage kidney disease (ESKD), as it is associated with reduced risk of mortality and cardiovascular events, and enhanced quality of life compared to maintenance dialysis [1]

We are here to support you every step of the way

Other Common Side Effects Beyond digestive issues, some people experience: Injection site reactions: Redness, swelling, or irritation where you inject the medication Fatigue: Feeling more tired than usual, especially when starting treatment Headaches: Usually mild and temporary Dizziness: May occur, particularly when blood sugar levels improve Serious but Rare Side Effects While GLP-1 medications are generally safe, some serious side effects can occur

Surg J 07:e158e162

Drink more fluids

Analyzing mitochondrial dysfunction, oxidative stress, and apoptosis: potential role of L-carnitine